Skip to content

The effect of Transcranial Magnetic Stimulation in patients with Methamphetamine Use Disorder

Evaluate The Effect of Transcranial Magnetic Stimulation (TMS) on craving in Patients with Methamphetamine Use Disorder.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180317039114N1
Enrollment
50
Registered
2021-03-01
Start date
2018-07-13
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients' obsession with methamphetamine. Obsessive-compulsive behavior

Interventions

Intervention 1: Intervention group: In the treatment position, in the form of receiving transcranial electrical stimulation, which is performed in the form of 20 sessions of therapy for 4 weeks and ea

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Men aged 20 to 50 years craving score of 28 or more on methamphetamine having a negative urine test at the beginning and duration of the study no history of counseling and psychotherapy during this period.

Exclusion criteria

Exclusion criteria: history of concussion or seizures in the person history of bipolar disorder or severe psychological symptoms use of other psychotropic substances severe physical illness lack of metal, prosthesis, shunt in the skull no heartbeat

Design outcomes

Primary

MeasureTime frame
Methamphetamine temptation score in Desires for Drug Questionnaire. Timepoint: Before the intervention, 7, 45 days after the start. Method of measurement: Desires for Drug Questionnaire (DDQ questionnaire).

Secondary

MeasureTime frame
Quality of life score. Timepoint: Before the intervention, 7.45 days later. Method of measurement: Criteria for the Fifth Diagnostic and Statistical Guidelines for Mental Disorders.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Batebi

Qazvin University of Medical Sciences

r.batebi@qums.ac.ir+98 28 3355 0188

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026